A Phase 1, Open-Label, Randomized, Single Dose, Parallel Design Study To Estimate The Relative Bioavailability Of Co Administered Formulations Of Azithromycin Microsphere (AZ) And Chloroquine Test Formulation (CQ) Compared With Co Administered Immediate Release Individual AZ And CQ Tablets In Healthy Adult Subjects.

Trial Profile

A Phase 1, Open-Label, Randomized, Single Dose, Parallel Design Study To Estimate The Relative Bioavailability Of Co Administered Formulations Of Azithromycin Microsphere (AZ) And Chloroquine Test Formulation (CQ) Compared With Co Administered Immediate Release Individual AZ And CQ Tablets In Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Aug 2010

At a glance

  • Drugs Azithromycin; Chloroquine; Chloroquine/azithromycin
  • Indications Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Otitis media; Respiratory tract infections
  • Focus Pharmacokinetics
  • Acronyms AZCQ
  • Sponsors Pfizer
  • Most Recent Events

    • 06 Aug 2010 Actual initiation date (Jun 2010) added as reported by ClinicalTrials.gov.
    • 06 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Jun 2010 Actual initiation date (Apr 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top